1. Home
  2. CYTK vs ALSN Comparison

CYTK vs ALSN Comparison

Compare CYTK & ALSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$62.51

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Allison Transmission Holdings Inc.

ALSN

Allison Transmission Holdings Inc.

HOLD

Current Price

$99.00

Market Cap

7.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
ALSN
Founded
1997
1915
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.4B
IPO Year
2004
2012

Fundamental Metrics

Financial Performance
Metric
CYTK
ALSN
Price
$62.51
$99.00
Analyst Decision
Strong Buy
Hold
Analyst Count
16
7
Target Price
$78.94
$95.14
AVG Volume (30 Days)
1.7M
1.2M
Earning Date
11-05-2025
10-29-2025
Dividend Yield
N/A
1.09%
EPS Growth
N/A
N/A
EPS
N/A
8.15
Revenue
$87,211,000.00
$3,069,000,000.00
Revenue This Year
$361.33
N/A
Revenue Next Year
$65.14
$0.10
P/E Ratio
N/A
$12.12
Revenue Growth
2609.26
N/A
52 Week Low
$29.31
$76.01
52 Week High
$69.33
$121.81

Technical Indicators

Market Signals
Indicator
CYTK
ALSN
Relative Strength Index (RSI) 49.62 71.86
Support Level $59.37 $97.04
Resistance Level $63.80 $100.66
Average True Range (ATR) 2.56 2.35
MACD -0.44 0.35
Stochastic Oscillator 42.46 77.35

Price Performance

Historical Comparison
CYTK
ALSN

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ALSN Allison Transmission Holdings Inc.

Allison Transmission is the largest manufacturer of fully automatic transmissions for medium- and heavy-duty commercial vehicles. Its automatic transmissions allow customers to achieve better fuel and operator efficiency than less expensive manual and automated manual transmissions. Allison serves several end markets, including on- and off-highway equipment and military vehicles. Its on-highway business commands approximately 60% global market share. The company's transmissions can be found in Class 4-8 trucks, buses, and a limited number of large passenger vehicles (heavy-duty pickup trucks and motorhomes). Allison also produces commercial hybrid propulsion systems and is developing fully electric powertrains.

Share on Social Networks: